These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [The prevention of chrysotherapy complications in patients with rheumatoid arthritis]. Berezhnitskiĭ MN; Ornat SIa; Aleksandruk DP Vrach Delo; 1989 Apr; (4):55-7. PubMed ID: 2756689 [TBL] [Abstract][Full Text] [Related]
28. Oral pulsed dexamethasone therapy in early rheumatoid arthritis: a pilot study. Kroot EJ; Huisman AM; Van Zeben J; Wouters JM; Van Paassen HC Ann N Y Acad Sci; 2006 Jun; 1069():300-6. PubMed ID: 16855157 [TBL] [Abstract][Full Text] [Related]
29. [Gold treatment of rheumatoid arthritis]. Wagner H; Wirth W Z Rheumatol; 1978; 37(1-2):4-11. PubMed ID: 415451 [TBL] [Abstract][Full Text] [Related]
31. A reevaluation of aspirin therapy in rheumatoid arthritis. Fries JF; Ramey DR; Singh G; Morfeld D; Bloch DA; Raynauld JP Arch Intern Med; 1993 Nov; 153(21):2465-71. PubMed ID: 8215751 [TBL] [Abstract][Full Text] [Related]
32. Chrysotherapy: a synoptic review. Eisler R Inflamm Res; 2003 Dec; 52(12):487-501. PubMed ID: 14991077 [TBL] [Abstract][Full Text] [Related]
33. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721 [TBL] [Abstract][Full Text] [Related]
34. Nonsteroidal anti-inflammatory agents in arthritis. Ridolfo AS Am Fam Physician; 1978 Feb; 17(2):131-8. PubMed ID: 622939 [TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of injectable gold in rheumatoid arthritis. Clark P; Tugwell P; Bennett K; Bombardier C J Rheumatol; 1989 Apr; 16(4):442-7. PubMed ID: 2664167 [TBL] [Abstract][Full Text] [Related]
36. Factors influencing length of time taking methotrexate in rheumatoid arthritis. Ortendahl M; Schettler JD; Fries JF J Rheumatol; 2000 May; 27(5):1139-47. PubMed ID: 10813279 [TBL] [Abstract][Full Text] [Related]
37. [Concentration of gold in macrophages of the bone marrow in rheumatic diseases subjected to chrysotherapy]. Galle P; Villiaumey J Rev Rhum Mal Osteoartic; 1982 Mar; 49(4):273-9. PubMed ID: 7089467 [TBL] [Abstract][Full Text] [Related]
38. [Comparison of treatment outcome in patients with rheumatoid arthritis treated with TFX- Polfa or gold salts after a one year follow up]. Lewandowicz J Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1102-4. PubMed ID: 1305735 [TBL] [Abstract][Full Text] [Related]
39. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group. Kalden JR; Scott DL; Smolen JS; Schattenkirchner M; Rozman B; Williams BD; Kvien TK; Jones P; Williams RB; Oed C; Rosenburg R; J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964 [TBL] [Abstract][Full Text] [Related]
40. [The effect of combined drug treatment using gold preparations on indices of lipid peroxidation in patients with rheumatoid arthritis]. Makarchuk OS Vrach Delo; 1990 Mar; (3):70-2. PubMed ID: 1973321 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]